Clinical Trial Update: A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating NicaPlant in patients with aneurysmal subarachnoid hemorrhage undergoing aneurysm clipping has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• NicaPlantae

Snippet

Sponsor: BIT Pharma GmbH | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED